- $55.57m
- $47.69m
- $56.04m
- 45
- 50
- 84
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 55.7 | 48.5 | 64.3 | 75.9 | 56 |
Cost of Revenue | |||||
Gross Profit | 25.3 | 22.6 | 24.6 | 28 | 20.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 55.4 | 51.7 | 76.4 | 84.5 | 68.4 |
Operating Profit | 0.38 | -3.18 | -12.1 | -8.58 | -12.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.09 | -3.01 | -12.1 | -8.57 | -12.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.926 | -3.28 | -10.1 | -8.66 | -12.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.926 | -3.28 | -10.1 | -8.66 | -12.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.926 | -3.28 | -10.1 | -8.66 | -12.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.092 | -0.338 | -1.01 | -0.85 | -1.2 |